Patents Assigned to Barros Research Institute
  • Patent number: 7550150
    Abstract: The present invention relates to methods of treating or preventing a disease, disorder or condition associated with a viral infection using a dosing and resting regimen for administering a pharmaceutical composition that provides ARP.
    Type: Grant
    Filed: March 14, 2006
    Date of Patent: June 23, 2009
    Assignee: Barros Research Institute
    Inventors: Barnett Rosenberg, John W. Judge
  • Publication number: 20090136999
    Abstract: The present invention provides compositions and methods for the prevention and treatment of primary and metastatic neoplastic diseases and infectious diseases, for stimulating an immune response in a subject, and for use as an alternative to interleukin-12 (IL-12) treatment. In particular, the present invention provides Apicomplexa-related proteins (ARPs) that have immune stimulatory activity and thus have uses in the treatment and prevention of cancer and infectious diseases and in immune modulation. Compositions comprising an ARP are provided. Methods of use of an ARP for the prevention and/or treatment of cancer and/or infectious diseases, for use as an alternative to interleukin-12 (IL-12) treatment, and for eliciting an immune response in a subject, are also provided.
    Type: Application
    Filed: April 14, 2008
    Publication date: May 28, 2009
    Applicants: Michigan State University, Barros Research Institute
    Inventors: Charles Aylsworth, Siu-Cheong Ho, David Juckett, John W. Judge, Barnett Rosenberg, Igor V. Zlatkin, Tatiana Zlatkin
  • Patent number: 7393534
    Abstract: The present invention provides compositions and methods for the prevention and treatment of primary and metastatic neoplastic diseases and infectious diseases, for stimulating an immune response in a subject, and for use as an alternative to interleukin-12 (IL-12) treatment. In particular, the present invention provides Apicomplexa-related proteins (ARPs) that have immune stimulatory activity and thus have uses in the treatment and prevention of cancer and infectious diseases and in immune modulation. Compositions comprising an ARP are provided. Methods of use of an ARP for the prevention and/or treatment of cancer and/or infectious diseases, for use as an alternative to interleukin-12 (IL-12) treatment, and for eliciting an immune response in a subject, are also provided.
    Type: Grant
    Filed: July 15, 2004
    Date of Patent: July 1, 2008
    Assignee: Barros Research Institute
    Inventors: Charles Aylsworth, Siu-Cheong Ho, David Juckett, John W. Judge, Igor V. Zlatkin, Tatiana Zlatkin
  • Publication number: 20060211027
    Abstract: The present invention relates to methods of treating or preventing a disease, disorder or condition associated with a viral infection using a dosing and resting regimen for administering a pharmaceutical composition that provides ARP.
    Type: Application
    Filed: March 14, 2006
    Publication date: September 21, 2006
    Applicant: Barros Research Institute
    Inventors: Barnett Rosenberg, John Judge
  • Publication number: 20050058658
    Abstract: The present invention provides compositions and methods for the prevention and treatment of an infectious disease caused by infection with HIV and for stimulating an immune response in a subject. In particular, the present invention provides Apicomlexa-related proteins (ARPs) that have immune stimulatory activity and thus have uses in the treatment and prevention of an infectious disease caused by infection with HIV and in immune modulation. Compositions comprising an ARP are provided. Methods of use of an ARP for the prevention and/or treatment of an infectious disease caused with infection with HIV, and for eliciting an immune response in a subject, are also provided.
    Type: Application
    Filed: July 15, 2004
    Publication date: March 17, 2005
    Applicant: Barros Research Institute
    Inventor: Barnett Rosenberg